1. Managing Patients at High Risk for Hereditary Breast Cancer: A Guide for the Practicing Physician

   • James C. Cusack Jr.
   • Kevin S. Hughes

   Risk Assessment and Genetic Testing for Hereditary Breast Cancer 13 March 2012 Pages: 1721 - 1722

2. Hereditary Breast Cancer: Practical Pursuit for Clinical Translation

   • Henry T. Lynch
   • Carrie Snyder
   • Jane Lynch

   Risk Assessment and Genetic Testing for Hereditary Breast Cancer 21 March 2012 Pages: 1723 - 1731

   

3. Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers

   • Brian Drohan
   • Constance A. Roche
   • Kevin S. Hughes

   Risk Assessment and Genetic Testing for Hereditary Breast Cancer 17 March 2012 Pages: 1732 - 1737

   

4. Managing the Breast in Patients Who Test Positive for Hereditary Breast Cancer

   • David Euhus

   Risk Assessment and Genetic Testing for Hereditary Breast Cancer 07 March 2012 Pages: 1738 - 1744

   

5. Publication and Interpretation of Clinical Trial Results: The Need for Caution

   • J. F. Thompson
   • A. Hong
   • G. Fogarty

   Melanomas 05 April 2012 Pages: 1745 - 1747

6. Has the Survival Rate for Surgically Resected Gastric Gastrointestinal Stromal Tumors Improved in the Tyrosine Kinase Inhibitor Era?

   • Felipe E. Pedroso
   • Chandrajit P. Raut
   • Leonidas G. Koniaris

   Healthcare Policy and Outcomes 31 January 2012 Pages: 1748 - 1758

   

7. Development and Evaluation of a Checklist to Support Decision Making in Cancer Multidisciplinary Team Meetings: MDT-QuIC

   • B. W. Lamb
   • N. Sevdalis
   • J. S. A. Green

   Healthcare Policy and Outcomes 30 December 2011 Pages: 1759 - 1765

   

8. The Role of Tumor Markers in the Surgical Approach of Ovarian Masses in Pediatric Age: A 10-Year Study and a Literature Review

   • Claudio Spinelli
   • Valentina Pucci
   • Clara Ugolini

   Healthcare Policy and Outcomes 10 February 2012 Pages: 1766 - 1773

   

9. Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients

   • Terence C. Chua
   • Richard A. Scolyer
   • John F. Thompson

   Melanomas 31 January 2012 Pages: 1774 - 1781

   

10. Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma

    • Rajmohan Murali
    • Lauren E. Haydu
    • Richard A. Scolyer

    Melanomas 14 February 2012 Pages: 1782 - 1789

    

11. Prognostication of Soft Tissue Sarcomas Based on Chromosome 17q Gene and Protein Status: Evaluation of TOP2A, HER-2/neu, and Survivin

    • Isabela Werneck da Cunha
    • Louise De Brot
    • José Vassallo

    Bone and Soft Tissue Sarcomas 28 December 2011 Pages: 1790 - 1799

    

12. Long-Term Outcome of Isolated Limb Perfusion in Advanced Soft Tissue Sarcoma of the Extremity

    • R. Olofsson
    • P. Bergh
    • J. Mattsson

    Bone and Soft Tissue Sarcomas 05 January 2012 Pages: 1800 - 1807

    

13. Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

    • Christoph Tausch
    • Susanne Taucher
    • Michael Gnant

    Breast Oncology 30 December 2011 Pages: 1808 - 1817

    

14. Factors Affecting Lymph Node Yield in Patients Undergoing Axillary Node Dissection for Primary Breast Cancer: A Single-Institution Review

    • Marie Catherine Lee
    • Robert Plews
    • Christine Laronga

    Breast Oncology 28 December 2011 Pages: 1818 - 1824

    

15. Accuracy of Predicting Axillary Lymph Node Positivity by Physical Examination, Mammography, Ultrasonography, and Magnetic Resonance Imaging

    • Stephanie A. Valente
    • Gary M. Levine
    • Stephen F. Sener

    Breast Oncology 07 January 2012 Pages: 1825 - 1830

    

16. HOXB9 Expression Promoting Tumor Cell Proliferation and Angiogenesis Is Associated with Clinical Outcomes in Breast Cancer Patients

    • Hirohito Seki
    • Tetsu Hayashida
    • Yuko Kitagawa

    Breast Oncology 07 March 2012 Pages: 1831 - 1840

    

17. High Intersystem Variability for the Prediction of Additional Axillary Non-Sentinel Lymph Node Involvement in Individual Patients with Sentinel Node-Positive Breast Cancer

    • Ingrid van den Hoven
    • Gerrit P. Kuijt
    • Rudi M. H. Roumen

    Breast Oncology 30 December 2011 Pages: 1841 - 1849

    

18. Paget’s Disease as a Local Recurrence after Nipple-Sparing Mastectomy: Clinical Presentation, Treatment, Outcome, and Risk Factor Analysis

    • Visnu Lohsiriwat
    • Stefano Martella
    • Jean Yves Petit

    Breast Oncology 10 February 2012 Pages: 1850 - 1855

19. Training a New Generation of Breast Surgeons: Are We Succeeding?

    • Lisa M. Sclafani
    • Aaron Bleznak
    • Mahmoud B. El-Tamer

    Breast Oncology 05 January 2012 Pages: 1856 - 1861

    

20. Does the Final Intraoperative PTH Level Really Have to Fall into the Normal Range to Signify Cure?

    • Alexandra E. Reiher
    • Sarah Schaefer
    • Rebecca S. Sippel

    Endocrine Tumors 28 December 2011 Pages: 1862 - 1867

    

21. Clinical Efficacy of Sentinel Lymph Node Biopsy Using Methylene Blue Dye in Clinically Node-Negative Papillary Thyroid Carcinoma

    • Yong Bae Ji
    • Keon Joong Lee
    • Kyung Tae

    Endocrine Tumors 12 October 2011 Pages: 1868 - 1873

    

22. Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients

    • Hadiza S. Kazaure
    • Sanziana A. Roman
    • Julie A. Sosa

    Endocrine Tumors 08 November 2011 Pages: 1874 - 1880

    

23. What is the Best Criterion for the Interpretation of Adrenal Vein Sample Results in Patients with Primary Hyperaldosteronism?

    • Richard Webb
    • Aarti Mathur
    • Electron Kebebew

    Endocrine Tumors 03 November 2011 Pages: 1881 - 1886

    

24. Risk of Subsequent Primary Thyroid Cancer after Another Malignancy: Latency Trends in a Population-based Study

    • Geeta Lal
    • Megan Groff
    • Charles F. Lynch

    Endocrine Tumors 07 January 2012 Pages: 1887 - 1896

    

25. A Comparison of Outcomes for Younger and Older Adult Patients Undergoing Surgery for Primary Hyperparathyroidism

    • Emad Kandil
    • Dewan Safwan Majid
    • Ralph P. Tufano

    Endocrine Tumors 30 December 2011 Pages: 1897 - 1901

    

26. Cytokeratin 7 is a Predictive Marker for Survival in Patients with Esophageal Squamous Cell Carcinoma

    • Naohide Oue
    • Tsuyoshi Noguchi
    • Wataru Yasui

    Thoracic Oncology 28 December 2011 Pages: 1902 - 1910

    

27. Significance of Lymph Node Capsular Invasion in Esophageal Squamous Cell Carcinoma

    • Makoto Sakai
    • Shigemasa Suzuki
    • Hiroyuki Kuwano

    Gastrointestinal Oncology 31 January 2012 Pages: 1911 - 1917

    

28. Evaluation of the Seventh Edition of American Joint Committee on Cancer TNM Staging System for Gastric Cancer: Results from a Chinese Monoinstitutional Study

    • Zhe Sun
    • Zhen-ning Wang
    • Hui-mian Xu

    Gastrointestinal Oncology 13 January 2012 Pages: 1918 - 1927

    

29. Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment

    • George A. Poultsides
    • Lyen C. Huang
    • Richard D. Schulick

    Gastrointestinal Oncology 14 December 2011 Pages: 1928 - 1935

    

30. Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer

    • Kazumasa Fujitani
    • Masayuki Mano
    • Toshimasa Tsujinaka

    Gastrointestinal Oncology 21 December 2011 Pages: 1936 - 1943

    

31. Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer

    • Teppei Morikawa
    • Aya Kuchiba
    • Shuji Ogino

    Gastrointestinal Oncology 22 December 2011 Pages: 1944 - 1953

    

32. Ex Vivo Evaluation of Preoperatively Treated Rectal Cancer Specimens of Patients Undergoing Radical Resection

    • Sebastian G. de la Fuente
    • Kirk A. Ludwig
    • Christopher R. Mantyh

    Colorectal Cancer 14 February 2012 Pages: 1954 - 1958

    

33. Sentinel Lymph Node Procedure Leads to Upstaging of Patients with Resectable Colon Cancer: Results of the Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer

    • Carsten T. Viehl
    • Ulrich Guller
    • Markus Zuber

    Colorectal Cancer 10 February 2012 Pages: 1959 - 1965

    

34. Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer

    • Hyun Hoon Chung
    • Hyun Woo Kwon
    • Jae Weon Kim

    Gynecologic Oncology 29 November 2011 Pages: 1966 - 1972

    

35. Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study

    • Hee Seung Kim
    • Chel Hun Choi
    • Jae Weon Kim

    Gynecologic Oncology 20 December 2011 Pages: 1973 - 1979

    

36. Comparison of Acute Toxicities in Two Primary Chemoradiation Regimens in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma

    • Katherine Y. Fan
    • Hrishikesh Gogineni
    • Patrick K. Ha

    Head and Neck Oncology 31 January 2012 Pages: 1980 - 1987

37. Feasibility of Sentinel Node Biopsy in Head and Neck Melanoma Using a Hybrid Radioactive and Fluorescent Tracer

    • Oscar R. Brouwer
    • W. Martin C. Klop
    • Fijs W. B. van Leeuwen

    Head and Neck Oncology Open access 30 December 2011 Pages: 1988 - 1994

    

38. Treatment for T1-2 Oral Squamous Cell Carcinoma with or Without Perineural Invasion: Neck Dissection and Postoperative Adjuvant Therapy

    • Shyh-Kuan Tai
    • Wing-Yin Li
    • Peter Mu-Hsin Chang

    Head and Neck Oncology 28 December 2011 Pages: 1995 - 2002

    

39. The Determining Risk Factors for Treatment Outcomes in Patients with Squamous Cell Carcinoma of the Hard Palate

    • Fan-Yu Meng
    • Jeng-Yuh Ko
    • Tseng-Cheng Chen

    Head and Neck Oncology 20 January 2012 Pages: 2003 - 2010

    

40. SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis

    • Hsieh-Cheng Chen
    • Yung-Ming Jeng
    • Yu-Ling Chen

    Hepatobiliary Tumors 07 December 2011 Pages: 2011 - 2019

    

41. Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma

    • T. Piardi
    • F. Gheza
    • Patrick Pessaux

    Hepatobiliary Tumors 17 December 2011 Pages: 2020 - 2026

    

42. Predictors for Microinvasion of Small Hepatocellular Carcinoma ≤2 cm

    • Yo-ichi Yamashita
    • Eiji Tsuijita
    • Yoshihiko Maehara

    Hepatobiliary Tumors 28 December 2011 Pages: 2027 - 2034

    

43. Evolution of Long-Term Outcome of Liver Resection for Colorectal Metastases: Analysis of Actual 5-Year Survival Rates over Two Decades

    • Luca Viganò
    • Nadia Russolillo
    • Lorenzo Capussotti

    Hepatobiliary Tumors 05 January 2012 Pages: 2035 - 2044

    

44. Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

    • Ching-Wei D. Tzeng
    • Jason B. Fleming
    • Matthew H. G. Katz

    Pancreatic Tumors 19 January 2012 Pages: 2045 - 2053

    

45. Association of Type O Blood with Pancreatic Neuroendocrine Tumors in Von Hippel–Lindau Syndrome

    • Allison B. Weisbrod
    • David J. Liewehr
    • Electron Kebebew

    Pancreatic Tumors 16 February 2012 Pages: 2054 - 2059

    

46. Usefulness of Transcription–Reverse Transcription Concerted Reaction Method for Detecting Circulating Tumor Cells in Patients With Colorectal Cancer

    • Nobutaka Sato
    • Naoko Hayashi
    • Hideo Baba

    Translational Research and Biomarkers 06 July 2011 Pages: 2060 - 2065

    

47. Clinicopathological Significance of BMP7 Expression in Esophageal Squamous Cell Carcinoma

    • Koichi Megumi
    • Sumiya Ishigami
    • Shoji Natsugoe

    Translational Research and Biomarkers Open access 13 September 2011 Pages: 2066 - 2071